BEYOND: a randomized controlled trial comparing efficacy and safety of individualized follitropin delta dosing in a GnRH agonist versus antagonist protocol during the first ovarian stimulation cycle.
Rita LoboTerje SoerdalErling EkerhovdBen J CohlenEleonora PorcuMichael SchenkYoel ShufaroJesper SmeenkMoritz B SuerdieckPhilippe PintonAnja Pinborgnull nullPublished in: Human reproduction (Oxford, England) (2024)
2 May 2019.
Keyphrases